SCHEMBL4960988

SCHEMBL4960988

CC(O)c1ccc2[nH]c3ncccc3c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPT P10636 4/20 0.43
AURKA O14965 2/20 0.41
PARP1 P09874 1/20 0.41
PIKFYVE Q9Y2I7 1/20 0.40
PLG P00747 1/20 0.38
PLAU P00749 1/20 0.38
FEN1 P39748 1/20 0.37
ALK Q9UM73 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
UGT2B7 P16662 1/20 0.37
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
MAP4K4 O95819 1/20 0.36
PAK4 O96013 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30304698 0.88 CHEK1 (0.49) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL4960062 0.85 MET (0.39) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL4960647 0.77 MET (0.42) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL2628367 0.76 ACHE (0.56) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL4958620 0.74 CHEK1 (0.50) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL675383 0.73 ERBB2 (0.55) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL4959114 0.73 BRD4 (0.43) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL4961015 0.73 CHEK1 (0.53) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL4961010 0.73 CHEK1 (0.53) CHEK1MEN1KMT2AMAPTAURKA
SCHEMBL674822 0.73 CHUK (0.54) CHEK1MEN1KMT2AMAPTAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896472-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2008-03-12 EP disclosed
US-20070004684-A1 Alpha-Carbolines as CDK-1 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-04 US disclosed
US-20070004684-A1 Alpha-Carbolines as CDK-1 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-04 US disclosed
US-20070004684-A1 Alpha-Carbolines as CDK-1 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-04 US disclosed
WO-2006131552-A1 ALPHA-CARBOLINES AS CDK-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004684-A1 Alpha-Carbolines as CDK-1 inhibitors CDKL1, CDK1, CCNA1 CHEK1 75/4885MEN1 1425/4885KMT2A 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.